CPS Publications
Pipeline Trends
UMass Medical School’s Clinical Pharmacy Services closely monitors drugs in the pharmaceutical pipeline. In our biannual publication, Pipeline Trends, we offer concise, impartial data on medications in development and their potential place in therapy. The information in Pipeline Trends helps subscribers plan for future initiatives.
In the 2009 issue of Pipeline Trends, available as a complimentary sample 
, we report on investigational indications such as HPV prevention in boys using Gardasil and jet lag treatment with Nuvigil. In this issue, our team also highlights promising new agents, including specialty drugs, for a range of conditions:
- Atrial fibrillation
- COPD
- Multiple sclerosis
- Psoriasis
- Pulmonary hypertension
- Osteoporosis
- Seizures
- Treatment-failure gout
Our publication also forecasts pertinent industry trends and relevant pipeline updates.
To subscribe to this service, please contact Karen Lee at (508) 856-4545 or Karen.Lee@umassmed.edu.
CPS Insider
UMass Medical School’s Clinical Pharmacy Services provides our clients with up-to-date synopses of new drug entities and developments, legislative action, and other clinical information through the quarterly CPS Insider. This complimentary resource delivers valuable market intelligence about the latest cutting-edge drugs and drug delivery systems.
Current Issue
CPS Insider, July-September 2009 
Archive
CPS Insider, April–June 2009
CPS Insider, Jan.–March 2009
CPS Insider, Oct.–Dec. 2008
CPS Insider, July–Sept. 2008
CPS Insider, April–June 2008
CPS Insider, Jan.–March 2008
CPS Insider, Oct.–Dec. 2007
CPS Insider, July–Sept. 2007